Multiparametric MRI (eg, LiverMultiScan)
Simultaneous quantification of steatosis and fibro-inflammatory activity (cT1) on standard MRI scanners without elastography hardware.
Unlike MRE, which needs special vibration paddles attached to the MRI scanner, LiverMultiScan uses software on standard MRI machines to measure liver fat, iron, and a tissue signal called iron-corrected T1 (cT1, reported in milliseconds). Because active inflammation and swelling hold extra fluid in liver tissue, cT1 rises when MASH is inflamed and scarring: under 825 ms makes 'at-risk' MASH unlikely, while 875 ms or higher points strongly toward active MASH with at least moderate fibrosis.
What Is mpMRI (eg, LiverMultiScan)?
- mpMRI combines multiple MRI techniques into a single scan for comprehensive tissue evaluation1
- LiverMultiScan is proprietary software developed by Perspectum Diagnostics (Oxford, UK) that postprocesses mpMRI scans to quantify steatosis, fibrosis, and inflammation1,2
How Is It Performed?
- The patient undergoes MRI scans which are used to compute cT1 and liver fat percentage2
Use in MASLD/MASH Care
- MRI cT1 helps risk-stratify patients when other noninvasive tests are inconclusive or not reflective of clinical suspicion4
Strengths
- Compatible with standard MRI units; no elastography needed5
- Simultaneously quantifies steatosis, fibrosis, and inflammation in one noninvasive scan for a comprehensive liver assessment1,2
Limitations
- Depending on location, availability may be limited5
- The utility of cT1 to confidently rule out clinically inapparent stage 4 fibrosis has not been well demonstrated6
Published Cutoff Values to Rule In/Out “High-Risk MASH”a Using mpMRI3
| cT1, ms | Interpretation | Sensitivity,b % | Specificity,c % |
|---|---|---|---|
| <825 | “High-risk” MASH unlikely | 78 | 67 |
| ≥875 | “High-risk” MASH likely | 59 | 81 |